Brief: PeptiDream to set up Osaka-based special peptide drugs JV
Aug 7 (Reuters) - PeptiDream Inc 4587.T
* Says it plans to set up Osaka-based joint venture with
Shionogi & Co., Ltd 4507.T and Sekisui Chemical Co., Ltd.
4204.T , on Sept. 1
* Says the joint venture will be engaged in R&D, production
and sales of special peptide drugs
Source text in Japanese: https://goo.gl/XHhG9z
Further company coverage: 4587.T 4507.T 4204.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner